Mark Sullivan, J.D.

Mark Sullivan, J.D.

Chief Legal OfficeratDefinium Therapeutics· In proxies 2023–2024

Pay in FY2024+7% from the year before · Definium Therapeutics stock +90.2% the same year

Mark Sullivan, J.D. was paid $1.2M in FY2024 (Dec), up 7%. Definium Therapeutics stock rose 90.2% that year.

Pay$100 in the stock at the end of FY22 → $316
Pay is from the Summary Compensation Table of each Definium Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Definium TherapeuticsPublic company · 3 yr
    • Chief Legal Officer2023 – Present · 3 yrStock in role +1,578%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?